Inferior Vena Cava Diameter and Postpartum Hemorrhage
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03732079 |
|
Recruitment Status : Unknown
Verified November 2018 by HaEmek Medical Center, Israel.
Recruitment status was: Not yet recruiting
First Posted : November 6, 2018
Last Update Posted : November 6, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Excessive bleeding after normal birth or cesarean section is defined as blood loss of 1000 mL or more (clinically estimated) within 24 hours after birth. It occurs in about 5% among postpartum women. Postpartum hemorrhage is a leading cause of morbidity and mortality among women giving birth. Postpartum hemorrhage may lead to hemorrhagic shock, renal failure, respiratory failure, need for surgical intervention, blood transfusion and hysterectomy.
The cornerstone of effective treatment is rapid diagnosis and intervention in time. However, in a number of cases there is an underestimation of the volume of blood loss which may lead to delay in diagnosis and treatment. The consequences are even graver in women who delivered by a cesarean section, since unlike a normal birth in which the bleeding is external and visible, the bleeding is usually intra-abdominal, and so the delay in diagnosis may be even longer.
The Inferior Vena Cava (IVC) is a flexible blood vessel sensitive to intravascular blood volume, and its diameter varies accordingly. Its diameter reflects the pressure in the right atrium, which is a measure of the cardiac preload. A number of studies have shown that the IVC diameter changes, before the variations in vital and clinical signs.
Recently, IVC diameter has been assessed as an assessment of intravenous fluid balance in hemodynamically stable patients with a risk of sub-volume shock. The authors concluded that the IVC measurement is a good noninvasive method, compared to catheter insertion into the right atrium, and it is available as a bedside procedure.
In obstetrics the use of IVC to determine blood loos was not widely examined and there is no information regarding the use of IVC diameter as a predictor or as a detection method of postpartum bleeding.
In this study the investigators aim to examine the correlation between IVC diameter and the volume of postpartum blood loss.
| Condition or disease | Intervention/treatment |
|---|---|
| Other Immediate Postpartum Hemorrhage, With Delivery | Diagnostic Test: Ultrasound |
| Study Type : | Observational |
| Estimated Enrollment : | 108 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | The Correlation Between Inferior Vena Caval Diameter and the Volume of Postpartum Blood Loss |
| Estimated Study Start Date : | November 10, 2018 |
| Estimated Primary Completion Date : | April 30, 2019 |
| Estimated Study Completion Date : | April 30, 2019 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Research group
Women with early postpartum hemorrhage.
|
Diagnostic Test: Ultrasound
Ultrasound to measure the IVC diameter. The IVC diameter will be measured in the inspirium and the expirium, and the collapsibility index will be recorded. |
|
Control group
Postpartum women without abnormal bleeding.
|
Diagnostic Test: Ultrasound
Ultrasound to measure the IVC diameter. The IVC diameter will be measured in the inspirium and the expirium, and the collapsibility index will be recorded. |
- To examine the correlation between IVC diameter and the volume of postpartum blood loss. [ Time Frame: 6 months ]
- To create a normogram of IVC diameter in postpartum women and to check whether there is a cutt-of value that appears before the onset of clinical signs of blood loss. [ Time Frame: 6 months ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | Female |
| Gender Based Eligibility: | Yes |
| Gender Eligibility Description: | postpartum women |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Women over the age of 18 after birth
- Single pregnancy
- Vaginal birth
- Term pregnancy (gestational age between week 37-42)
- The newborn is appropriate for gestational age (10-90 percentile)
Exclusion Criteria:
- Gestational or pre-pregnancy hypertension
- Heart, liver, or chronic kidney disease
- Women who delivered newborn with major malformation
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03732079
| Contact: Manal Massalha, MD | 0506415166 | manal.massalha@clalit.org.il | |
| Contact: Raed Salim, MD | salim_ra@clalit.org.il |
| Principal Investigator: | Manal Massalha, Massalha | Emek Medical Center |
| Responsible Party: | HaEmek Medical Center, Israel |
| ClinicalTrials.gov Identifier: | NCT03732079 |
| Other Study ID Numbers: |
HaEmek |
| First Posted: | November 6, 2018 Key Record Dates |
| Last Update Posted: | November 6, 2018 |
| Last Verified: | November 2018 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | Yes |
|
Inferior Vena Cava Diameter |
|
Postpartum Hemorrhage Hemorrhage Pathologic Processes Obstetric Labor Complications |
Pregnancy Complications Puerperal Disorders Uterine Hemorrhage |

